These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34988293)

  • 21. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematological Parameters as Diagnostic Factors: Correlation with Severity of COVID-19.
    Dadkhah M; Matin S; Safarzadeh E; Rezaei N; Negaresh M; Salehzadeh H; Matin S; Sharifiazar A; Abazari M
    Acta Biomed; 2022 May; 93(2):e2022061. PubMed ID: 35546008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil-to-lymphocyte ratio as a predictor of clinical outcomes in critically ill COVID-19 patients: A retrospective observational study.
    Ali HS; Ananthegowda DC; Ebrahim EMA; Kannappilly N; Al Wraidat M; Mohamed AS; Khatib MY
    Health Sci Rep; 2022 Sep; 5(5):e844. PubMed ID: 36177401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil-to-Lymphocyte Ratio and Outcomes in Louisiana COVID-19 Patients.
    Tatum D; Taghavi S; Houghton A; Stover J; Toraih E; Duchesne J
    Shock; 2020 Nov; 54(5):652-658. PubMed ID: 32554992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study.
    La Torre G; Marte M; Massetti AP; Carli SM; Romano F; Mastroianni CM; Minorenti M; Alessandri F; Ajassa C; Fusconi M; De Vincentiis M; de Meo D; Villani C; Cardi M; Pugliese F;
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):1056-1064. PubMed ID: 35179773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count as Early Diagnostic Tools for Corona Virus Disease 2019.
    Shahid MF; Malik A; Siddiqi FA; Fazal I; Hammad M; Saeed A; Abbas N
    Cureus; 2022 Mar; 14(3):e22863. PubMed ID: 35399415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of disease severity and outcomes in pediatric patients with croup and COVID-19 in the pediatric emergency department.
    Lee EP; Mu CT; Yen CW; Hsia SH; Lin JJ; Chan OW; Chiu CC; Lai SH; Yang WC; Chen CY; Su YT; Wu HP
    Am J Emerg Med; 2023 Oct; 72():20-26. PubMed ID: 37453221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Neutrophil-to-lymphocyte Ratio at Admission Predict Severity and Mortality in COVID-19 Patients? A Systematic Review and Meta-analysis.
    Sarkar PG; Pant P; Kumar J; Kumar A
    Indian J Crit Care Med; 2022 Mar; 26(3):361-375. PubMed ID: 35519918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.
    Fouad SH; Allam MF; Taha SI; Okba AA; Hosny A; Moneer M; Roman SW
    J Int Med Res; 2021 Jul; 49(7):3000605211030124. PubMed ID: 34250826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Profiles, Characteristics, and Outcomes of the First 100 Admitted COVID-19 Patients in Pakistan: A Single-Center Retrospective Study in a Tertiary Care Hospital of Karachi.
    Asghar MS; Haider Kazmi SJ; Ahmed Khan N; Akram M; Ahmed Khan S; Rasheed U; Hassan M; Memon GM
    Cureus; 2020 Jun; 12(6):e8712. PubMed ID: 32699707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.
    Kumar Gothwal S; Singh VB; Shrivastava M; Banseria R; Goyal K; Singh S; Ali H; Saad Alharbi K; Singh Y; Gupta G
    Altern Ther Health Med; 2021 Jun; 27(S1):18-24. PubMed ID: 33609349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study.
    Noor A; Akhtar F; Tashfeen S; Anwar N; Saleem B; Khan SA; Akram Z; Shahid S
    J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S595-S601. PubMed ID: 33754514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematological Changes in the Second Wave of SARS-CoV-2 in North India.
    Singh A; Verma SP; Kushwaha R; Ali W; Reddy HD; Singh US
    Cureus; 2022 Mar; 14(3):e23495. PubMed ID: 35345814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of simple inflammatory biomarkers in patients with severe COVID-19: an observational study.
    Ntalouka MP; Pantazopoulos I; Brotis AG; Pagonis A; Vatsiou I; Chatzis A; Rarras CN; Kotsi P; Gourgoulianis KI; Arnaoutoglou EM
    Hippokratia; 2022; 26(2):70-77. PubMed ID: 37188050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.